February 12, 2025 Obinutuzumab Boosts Lupus Nephritis Treatment Success Phase 3 trial shows adding obinutuzumab to standard lupus nephritis therapy improved complete renal response rates by 13.4 percentage points over placebo, though serious infection risks increased.
